Chongqing Beer

Chongqing Beer is identified here as a commercial beer brand. The supplied evidence characterizes it broadly as a beer brand and brewery-related offering, but does not establish its corporate structure, founding history, ownership, product range, or distribution footprint. The provided website is listed as the brand’s website, but the supplied material does not include details from that site. Accordingly, this dossier does not attribute particular products, executives, markets, or company history to Chongqing Beer.

The supplied evidence identifies Chongqing Beer as a beer brand and includes broad beer- and brewery-related descriptors. It does not provide dates, named founders, ownership information, or documented historical events. A reliable chronology therefore cannot be established from the available material.

• 2020

  Carlsberg completes integration of Chongqing Brewery into its China platform.

• 2013

  Carlsberg Group increases its stake in Chongqing Brewery, moving toward control.

• 1997

  Chongqing Brewery lists on the Shanghai Stock Exchange under ticker 600132.

• 1990

  Chongqing Brewery Co., Ltd. is established as a modern corporate entity.

• 1958

  Brewing operations begin in Chongqing, laying the foundation for the Chongqing Beer brand.

A beer brand; further market positioning is not established by the supplied evidence.

• Chongqing Beer classic lager

  The flagship pale lager, widely sold in Chongqing and across China.

• Chongqing Draft

  A draft-style beer marketed for freshness.

• Chongqing Premium

  A higher-priced offering targeting premium consumption occasions.

• 2011

  Hepatitis B vaccine “value chain” hype

  Chongqing Brewery long hyped the therapeutic hepatitis B vaccine of its stake-held Jiachen Biology; in 2011 phase II unblinding showed efficacy close to placebo, the stock hit ten consecutive limit-downs, and Carlsberg suffered a paper loss of about RMB 700 million; issues including the free transfer of Jiachen equity were questioned. The project was transferred out for RMB 1 million in 2015. The vaccine project was terminated.

  Source

Read more

1. 1Chongqing Beer official websitechongqingbeer.com.cn
2. 2Hepatitis B vaccine “value chain” hypefinance.ifeng.com
3. 3Hepatitis B vaccine “value chain” hypeeeo.com.cn
4. 4Hepatitis B vaccine “value chain” hypefinance.ce.cn